Methods: A panel of experts reviewed the results of a comprehensive literature search and identified published studies relevant to the clinical question. These studies were classified according to the evidence-based methodology of the American Academy of Neurology. Objective outcomes of postoperative onset of paraparesis, paraplegia, and quadriplegia were used because no randomized or masked studies were available.
Paraparesis, paraplegia, and quadriplegia are complications of spinal surgery and certain surgeries of the aorta. Intraoperative monitoring (IOM) of neural function is used to warn of the risk of surgical complications. [1] [2] [3] [4] [5] [6] Anesthesiologists and surgeons are able to intervene in a variety of ways when IOM raises warnings. They can modify surgery by interventions such as reducing the degree of distraction, adjusting retractors, removing or adjusting grafts or hardware, reimplanting or unclamping arteries, placing vascular bypass grafts, minimizing the remaining portion of the surgery, or other actions. Surgeons also have the opportunity to check a wake-up test in some patients.
This evidence-based guideline seeks to answer the clinical question: Does IOM with somatosensory evoked potentials (SEPs) and transcranial electrical (tce) motor evoked potentials (MEPs) predict adverse surgical outcomes?
The panel addressed this question on the basis of subgroup analyses of well-defined patient cohorts, comparing the clinical outcomes of those patients who had evoked potential (EP) changes with those who had no EP changes. The panel recognized an inherent limitation in assessing the specificity of IOM changes when those changes resulted in clinical interventions by anesthesiologists or surgeons.
The panel applied the following reasoning:
1. If it can be shown that adverse IOM changes predict increased risk of adverse clinical outcomes consistently, then all adverse IOM changes may represent possible compromise of the spinal cord that might result in an adverse outcome. 2. Nonobjective outcomes are particularly problematic for assessing the usefulness of IOM because of the potential for diagnostic suspicion bias. Patients with abnormal IOM might be more thoroughly evaluated postoperatively than patients without intraoperative changes. Without masked outcome assessment and a standardized method of case ascertainment, only obvious outcomes (e.g., new paraplegia) are likely to be noticed in patients with normal IOM. Subtler changes, such as sensory changes, could easily be missed. This bias would tend to exaggerate the usefulness of IOM. Therefore, the only outcomes assessed were new paraparesis, paraplegia, and quadriplegia, because these neurologic deficits are more objective signs than are less-severe deficits.
DESCRIPTION OF THE ANALYTIC PROCESS
Seven physician clinical neurophysiologists were appointed to write this guideline (M.R.N., R.G.E., G. A research librarian performed literature searches of the MEDLINE and EMBASE databases using the following keywords: monitoring, intraoperative, evoked potentials, paralysis, and intraoperative complications. Additional articles were found from among the references cited in the reports reviewed. Each article was reviewed independently by at least 2 panel members. Appendix e-3 presents the complete MEDLINE search strategy, and appendix e-4 presents the complete EMBASE search strategy.
The panel elected to focus on the 2 most common current spinal cord IOM techniques. The SEP technique evaluated was ankle-wrist stimulation with neck-scalp recording. The MEP technique evaluated was tceMEP with muscle recording.
Minimum size for study inclusion was 100 patients for orthopedic procedures and 20 patients for neurosurgical or cardiothoracic procedures. Different numbers were used because the rates of adverse neurologic outcomes are lower for orthopedic spine procedures compared with those for neurosurgical and cardiothoracic procedures.
A study was included if it represented a consecutive series of a representative group of patients, preferably prospective; if the IOM followed a protocol established in advance; if the IOM changes were identified in real time, before outcomes were known; and if the clinical outcomes of interest (paraparesis, paraplegia, and quadriplegia) were clearly reported. Reports were reviewed and scored independently by all content expert panelists. Those panelists discussed and resolved by consensus the methodology, results, relevance, and conclusions for a few reports for which there was initial panel discrepancy.
Next, these articles were rated using the AAN 4-tiered (Class I-Class IV) classification of evidence scheme for rating diagnostic studies (appendix e-5), and conclusions and recommendations were linked to the strength of the evidence (appendix e-6). All articles that were rated Class I or Class II are listed in table e-1. The primary data evaluated were the results from a comparison of the group without EP changes with the group with EP changes in both the number of cases with new postoperative paraparesis, paraplegia, and quadriplegia and the number without these conditions. Descriptive statistics and the Fisher exact test were used for statistical analysis.
ANALYSIS OF EVIDENCE
The search identified an initial set of 604 reports. Of those, 40 articles met the inclusion criteria, but 28 were subsequently excluded because they contained Class III or IV data; did not address the outcomes of paraparesis, paraplegia, or quadriplegia; primarily assessed nerve roots instead of the spinal cord; or substantially relied on techniques beyond the scope of this guideline.
Twelve studies [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] provide evidence to assess the role of IOM in the prediction of adverse outcomes (table e-1), 4 of which were Class I. [7] [8] [9] [10] One Class I study 7 found that no events of paraparesis, paraplegia, or quadriplegia occurred in 17 IOM patients without EP changes, but 5 of these adverse events occurred in 16 IOM patients with EP changes (31%) (Fisher exact test p ϭ 0.0184). In the second Class I study, 8 no events of paraparesis, paraplegia, or quadriplegia occurred in 84 IOM patients without EP changes, but among 25 IOM patients with EP changes, 4 (16%) had adverse outcomes: 1 had paraplegia, 1 had quadriplegia, and 2 had worsening of preexisting paraparesis (Fisher exact test p ϭ 0.00369). In the third Class I study, 9 no events of paraparesis, paraplegia, or quadriplegia occurred in 45 IOM patients without EP changes, but 2 adverse events occurred in 5 IOM patients with EP changes (40%) (Fisher exact test p ϭ 0.0158). In the fourth Class I study, 10 no events of paraparesis, paraplegia, or quadriplegia occurred in 49 IOM patients without EP changes, but 8 adverse events occurred in 20 IOM patients with EP changes (40%) (Fisher exact test p ϭ 0.000148). Overall, events of paraparesis, paraplegia, or quadriplegia occurred in 16%-40% of IOM patients with EP changes, but no adverse outcome events occurred in patients without an EP change.
The other 8 articles were Class II. [11] [12] [13] [14] [15] [16] [17] [18] No events of paraparesis, paraplegia, or quadriplegia occurred in 108 of 1,378 IOM patients without EP changes, whereas these severe adverse outcome events occurred in 1%-100% of the 1-72 IOM patients with EP changes. Seven of these studies reached significance by Fisher exact test ( p Ͻ 0.05). [11] [12] [13] [14] [15] [16] 18 All studies were consistent in that all paraparesis, paraplegia, and quadriplegia events occurred in the IOM patients with EP changes, and none occurred in the IOM patients without EP changes.
This assessment did not undertake to evaluate lesser degrees of motor impairment, which would underestimate the overall adverse outcome rate. It did not assess radiculopathy or similar complications of lumbar fusion.
The one prospective comparative study 3 of motor outcomes in patients with IOM vs those without IOM was excluded from this assessment because it used graded motor power changes rather than the presence of paraparesis, paraplegia, and quadriplegia as its outcome measure. That cohort study measured motor outcome and the decision to monitor, not whether the monitoring showed intraoperative changes. The study showed a significant positive relationship between decision to monitor and better motor outcome.
CONCLUSION IOM is established as effective to predict an increased risk of the adverse outcomes of paraparesis, paraplegia, and quadriplegia in spinal surgery (4 Class I and 7 Class II studies).
RECOMMENDATION Surgeons and other members of the operating team should be alerted to the increased risk of severe adverse neurologic outcomes in patients with important IOM changes (Level A). 19 -24 have demonstrated that intervening after IOM alerts (as opposed to not intervening) reduces the risk of permanent neurologic injury. On this basis, it seems reasonable to assume that such interventions might improve outcomes in humans as well. It is unlikely that controlled human studies designed to determine the efficacy of post-IOM alert interventions will ever be performed.
CLINICAL CONTEXT
This analysis did not compare MEP with SEP. The 2 techniques differ slightly. MEP more directly monitors the motor pathway itself. One technique may change while the other remains stable, or one may change earlier than the other. MEP requires more restrictive anesthesia requirements, causes patient movement, and has less-clear criteria for raising an alarm. SEP can localize an injury or site of ischemia more exactly. The tceMEPs are often used intermittently because of movements that occur with the stimulus. Sometimes one technique can be accomplished throughout a case, whereas the other techniques cannot. As a result, it may be most appropriate for the surgeon, anesthesiologist, and neurophysiologic monitoring team to choose which techniques are most appropriate for an individual patient. Conducting both techniques together is a reasonable choice for many patients. Neither technique can predict the onset of paraplegia that is delayed until hours or days after the end of surgery. Neither technique should be considered to have perfect predictive ability when no EP change is seen; rare falsenegative monitoring has occurred.
1,2
The studies reported here varied somewhat in the criteria used to raise alerts. The specific criteria used are reported in table e-1.
These IOM studies involved a knowledgeable professional clinical neurophysiologist supervisor. These studies support performance of IOM when conducted under the supervision of a clinical neurophysiologist experienced with IOM.
2,25,26 IOM conducted by technicians alone or by an automated device is not supported by the studies reported here because these studies did not use that practice model and because there is a lack of identified well-designed published outcomes studies demonstrating efficacy with those practice models. 
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